|
End-of-day quote
Nasdaq
25/08/2026
|
5-day change | 1st Jan Change | ||
| 1.360 USD | +2.26% |
|
-0.73% | -27.66% |
| 06-15 | Waldencast plc Announces Fda Approval of Obagi Saypha Chiq Injectable Hyaluronic Acid Gel | CI |
| 06-15 | Waldencast Says US FDA Approves Obagi Saypha ChIQ Injectable Hyaluronic Acid Gel | MT |
| Market Cap | 161M 138M 129M 118M 223M 15.33B 225M 1.52B 593M 7.73B 604M 591M 25.61B | P/E 2026 * |
-1.94x | P/E 2027 * | -2.08x |
|---|---|---|---|---|---|
| Enterprise Value | 161M 138M 129M 118M 223M 15.33B 225M 1.52B 593M 7.73B 604M 591M 25.61B | EV / Sales 2026 * |
0.56x | EV / Sales 2027 * | 0.51x |
| Free-Float |
46% | Yield 2026 * |
-
| Yield 2027 * | - |
| 1 day | +2.26% | ||
| 1 week | -0.73% | ||
| Current month | -21.39% | ||
| 1 month | -19.53% | ||
| 3 months | +4.62% | ||
| 6 months | -20.93% | ||
| Current year | -27.66% |
| 1 week | 1.26 |  | 1.39 |
| 1 month | 1.26 | | 1.79 |
| Current year | 0.72 | | 2.01 |
| 1 year | 0.72 | | 3.22 |
| 3 years | 0.72 | | 12 |
| 5 years | 0.72 | | 12.1 |
| 10 years | 0.72 | | 12.1 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 60 | 30/07/2026 | |
Allison Malkin
IRC | Investor Relations Contact | - | - |
Elisabeth Milan
LAW | General Counsel | - | 01/09/2023 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 60 | 01/01/2021 | |
Aaron Chatterley
BRD | Director/Board Member | 60 | 01/12/2021 |
Juliette Hickman
BRD | Director/Board Member | 52 | 01/03/2021 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 30/07/26 | Fiscal year | Chief Financial Officer | 158,578 | 0.1313% | ||
| 30/07/26 | Issuer sale | Founder | -193,816 | 0.1605% | ||
| 30/07/26 | Issuer sale | Chief Executive Officer | -264,294 | 0.2188% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +2.26% | -0.73% | -22.73% | -82.29% | 161M | |
| -0.57% | -0.07% | +35.35% | +68.08% | 34.15B | |
| -0.29% | +3.96% | +2.45% | +31.95% | 23.09B | |
| +2.94% | +6.37% | +10.78% | - | 11.75B | |
| -8.29% | -12.28% | -43.53% | -49.54% | 3.54B | |
| -1.32% | -4.83% | +62.12% | +58.85% | 2.5B | |
| +1.27% | +0.50% | -36.46% | - | 1B | |
| +5.97% | +15.89% | +39.02% | +284.97% | 591M | |
| -0.59% | -6.11% | - | - | 489M | |
| -1.54% | +6.08% | +54.84% | -17.95% | 386M | |
| Average | -0.41% | +2.72% | +11.31% | +42.01% | 7.77B | |
| Weighted average by Cap. | -0.69% | +1.92% | +18.08% | +49.40% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 285M 245M 229M 209M 395M 27.2B 399M 2.7B 1.05B 13.72B 1.07B 1.05B 45.45B | 318M 272M 255M 233M 440M 30.31B 444M 3.01B 1.17B 15.29B 1.19B 1.17B 50.63B |
| Net income | -81.16M -69.54M -65.16M -59.52M -112M -7.74B -113M -769M -299M -3.9B -305M -298M -12.93B | -76.15M -65.25M -61.14M -55.85M -105M -7.26B -106M -721M -281M -3.66B -286M -280M -12.13B |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 25/08/26 | $1.360 | +2.26% | 333,658 |
| 24/08/26 | $1.330 | +2.31% | 181,435 |
| 21/08/26 | $1.300 | -3.70% | 634,839 |
| 20/08/26 | $1.350 | +1.50% | 291,528 |
| 19/08/26 | $1.330 | -2.92% | 351,712 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- WALD Stock
Select your edition
All financial news and data tailored to specific country editions
